Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Mar 28, 2012; 18(12): 1404-1409
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1404
Published online Mar 28, 2012. doi: 10.3748/wjg.v18.i12.1404
Table 3 Radiological and clinical evaluation after 3-dimensional conformal chemoradiotherapy
Before 3D-CRT | After 3D-CRT | P value | |
Tumor staging | |||
T2 and T3 | 0 | 40 (78.4%) | < 0.05 |
T4 | 34 (66.7%) | 11 (21.6%) | |
Tumor volume (mean ± SD, cm3) | 43.7 ± 10.2 | 28.8 ± 8.5 | < 0.05 |
Assessment of tumor response | |||
Complete and partial response | 57 (85.1%) | ||
No response | 10 (14.9%) | ||
Dysphagia grade | |||
≤ 3 | 6 (9.0%) | 55 (82.1%) | < 0.05 |
≥ 4 | 61 (91.0%) | 12 (17.9%) | |
Karnofsky performance status | |||
50-70 | 37 | 49 | 0.031 |
10-49 | 30 | 18 |
- Citation: Jiang XJ, Song MQ, Xin YN, Gao YQ, Niu ZY, Tian ZB. Endoscopic stenting and concurrent chemoradiotherapy for advanced esophageal cancer: A case-control study. World J Gastroenterol 2012; 18(12): 1404-1409
- URL: https://www.wjgnet.com/1007-9327/full/v18/i12/1404.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i12.1404